6th Ocular Diseases & Drug Discovery Conference is taking place on March
20-21, 2014 in San Diego, CA. The conference continues to offer
presentations on novel and innovative therapeutics in ocular drug development
and discovery. This forum allows for excellent networking, the exchange of
ideas, and sharing of challenges; all with a united common goal of bringing new
and innovative treatments to patients in the area of ophthalmology.
The conference features the following topics:
I. Novel Targets, Developments and Technologies
II. Models of Ocular Diseases and Clinical Relevance
III. Novel Drug Delivery Methods to the Anterior and Posterior Segments
IV. Clinical Development Advances & Updates
V. Safety Assessment and Regulatory Landscape in Ocular Drug Development
I. BD, Investments and Potential for Collaborations
II. Safety and Regulatory in Ocular Development
III. Novel Technologies for Patient Adherence & Compliance
The Ocular Diseases & Drug Discovery Conference promotes the
discovery of ocular disease drug development by bringing together leading
scientists, researchers and experts to discuss and collaborate on the latest
research and development, safety assessment, regulatory issues and drugs in
development for combating and curing age-related macular degeneration (AMD),
diabetic retinopathy, glaucoma, DME, uveitis and other ocular diseases.
We hope to see you in San Diego!
The 2014 Advisory
What Past Delegates Said About the Event:
"The GTC Ocular Diseases and Drug Development meeting was highly informative,
covered a wide range of novel technologies and therapeutic areas across the
spectrum of ocular diseases. Moreover, owing to its size, the meeting was ideal
for networking with scientists from the Pharmaceutical industry and academia. I
will definitely be back next year."
- Suliman Al-Fayoumi, Ph.D., M.B.A., Director, Pharmacology, Acucela Inc.
"This was a well run meeting that provided an opportunity to meet new people and
to learn new ideas that might help me advance my own research. It was a
productive and enjoyable experience."
- Carol Toris, Ph.D., Director, Glaucoma Research, University of Nebraska
“I have to congratulate GTC for organizing an excellent conference on Ocular
Drug Development. This conference brought together key opinion leaders involved
in ocular drug development from both academia and industry to discuss some of
the major issues such as those involving formulation, drug delivery and
predictive validity of pre-clinical disease models.”
- M. (Ken) Kengatharan, Ph.D.,M.B.A., President & CSO, Altheos, Inc.
"GTC's Ocular Disease and Drug Development meeting was perfectly orchestrated,
providing a nice balance of science and innovation with targeted networking
opportunities in the ophthalmology field."
- Christopher Stanley Chief Business Officer RxGen, Inc.
“Among all the meetings I attend, I really enjoy and look forward to the GTC
Ocular Diseases and Drug Development conference every year. It is a meeting that
allows for open discussions about ophthalmic drug development, challenges in
research and clinical trials and innovations. It is a conference driven by
research and common goals. It has been a pleasure to be involved and it is very
rewarding to see so many exceptional innovators in the field participating and
Barbara Wirostko, Chief Scientific Officer and Co-Founder, Jade Therapeutics;
Clinical Adjunct Associate Professor, Ophthalmology, University of Utah
BECOME A SPONSOR
GTC offers comprehensive sponsorship packages for all our
meetings, including presentation opportunities, exhibit and booth space, as
well as the event delegate list. All our packages can be customized to meet
your company's budget. For more information, please contact:
Amber Kempf at
+1 (626) 256-6405 x110 or